2020 Oncology Drugs Market Share, Restraints, Segments And Regions

1
Oncology Drugs Global Market Report 2020-30
Covid 19 Impact And Recovery
2
Oncology Drugs Market Characteristics

• The global oncology drugs market is expected to
  decline from 84.4 billion in 2019 to 75.5
  billion in 2020 at a compound annual growth rate
  (CAGR) of -10.6. The decline is mainly due to
  the COVID-19 outbreak and the measures to contain
  it. Hospitals across the world have postponed the
  chemo treatments for cancer patients due to covid
  positive cases in the hospitals. The sessions are
  delayed or postponed to prevent patients and
  staff from unnecessary exposure. The cancer
  treatment can lower the patients ability to
  fight infection. COVID-19 pandemic is affecting
  industries across the globe including the
  pharmaceutical sector. The disruptions due to
  extended factory closures in various countries,
  shortage of APIs and other chemicals, rise in
  prices of key ingredients, and slowed production
  are the key factors for this decline. The market
  is then expected to recover and grow at a CAGR of
  8 from 2021 and reach 113.7 billion in 2023.
• The Business Research Company published its
  Oncology Drugs Global Market Report 2020 which
  provides strategists, marketers and senior
  management with the critical information they
  need to assess the global Oncology Drugs market.
  The report provides in-depth analysis of the
  impact of COVID-19 on the market, along with
  revised market numbers due to the effects of the
  coronavirus.
• The report covers the Oncology Drugs markets
  segments- 1) By Type, Lung Cancer, Pancreatic
  Cancer, Breast Cancer, Prostate Cancer, Ovarian
  Cancer, Colorectal Cancer, Gastric Cancer, Kidney
  Cancer, Brain Tumor, Thyroid Cancer, Skin Cancer,
  Bladder Cancer, Cervical Cancer, Blood Cancer,
  Others (Kaposi Sarcoma, AIDS-Related Lymphoma,
  Anal Cancer, Bone Cancer, Retinoblastoma,
  Testicular Cancer, Hepatocellular (Liver) Cancer,
  Mouth Cancer, Neuroblastoma) 2) By Distribution
  Channel Hospital Pharmacies, Retail Pharmacies/
  Drug Stores, Others 3) By Route Of
  Administration Oral, Parenteral, Others 4) By
  Drug Classification Branded Drugs, Generic Drugs
  5) By Mode Of Purchase Prescription-Based Drugs,
  Over-The-Counter Drugs.
• The major regions included in the report are
  Asia-Pacific, Western Europe, Eastern Europe,
  North America, South America, Middle East, and
  Africa.

Click Here To View Complete Report
3
Major Key Players F. Hoffmann-La Roche
Ltd, Novartis AG, Gilead Sciences Inc, Bayer
AG, Takeda Pharmaceticals
Click Here To Get A Sample Report
4
Table Of Content

• 1. Executive Summary
• 2. Report Structure
• 3. Oncology Drugs Market Characteristics
• 4. Oncology Drugs Market Product Analysis
• 5. Oncology Drugs Market Supply Chain
• .....
• 20. Key Mergers And Acquisitions In The Oncology
  Drugs Market
• 21. Market Background Pharmaceutical Drugs
  Market
• 22. Recommendations
• 23. Appendix
• 24. Copyright And Disclaimer
• Click Here To Get A Sample Report

5
Get In Touch
Whatever your need be, at The Business Research
Company we provide research consulting solutions
for businesses, government agencies
consultancies, and market research companies.
6
Europe The Business Research Company 47
Anchorage Point, 42 Cuba Street, Canary Wharf,
London, England, E14 8NE. 44 207 1930
708 Email info_at_tbrc.info www.tbrc.info
Asia The Business Research Company, Horizon
Avenue, 8-2-603/b/s/1/2 Road Number 10 Banjara
Hills Hyderabad (India) 500033 91
8897263534 Email info_at_tbrc.info www.tbrc.info
Americas The Business Research Company 625 South
Avenue, Apt B204, Secane, Philadelphia, PA 19018,
USA 1 3156230293 Email info_at_tbrc.info www.tbrc.
info